These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1687300)

  • 41. Isolation of HIV from cultures of purified CD4+ lymphocytes.
    Nielsen C; Nielsen CM; Petersen JL; Gøtzsche PC; Pedersen C; Arendrup M; Vestergaard BF
    J Virol Methods; 1991 Nov; 35(1):15-25. PubMed ID: 1686877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absolute number versus percentage of T-helper lymphocytes in human immunodeficiency virus infection.
    Kessler HA; Landay A; Pottage JC; Benson CA
    J Infect Dis; 1990 Feb; 161(2):356-7. PubMed ID: 1967624
    [No Abstract]   [Full Text] [Related]  

  • 43. Serum IgE levels in 622 persons with human immunodeficiency virus infection: IgE elevation with marked depletion of CD4+ T-cells.
    Lucey DR; Zajac RA; Melcher GP; Butzin CA; Boswell RN
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):427-9. PubMed ID: 1971183
    [No Abstract]   [Full Text] [Related]  

  • 44. Current report--HIV. Laboratory testing for the presence of HIV infection and the progression of HIV disease.
    Goldschmidt RH
    J Am Board Fam Pract; 1990; 3(1):60-2. PubMed ID: 1968309
    [No Abstract]   [Full Text] [Related]  

  • 45. The Jules Bordet Lecture. Immunopathogenesis of HIV infection.
    Fauci AS
    Ann N Y Acad Sci; 1993 Jun; 685():408-19. PubMed ID: 8103314
    [No Abstract]   [Full Text] [Related]  

  • 46. Cell-mediated immune response to human immunodeficiency virus in homosexual men.
    Ranki A
    J Infect Dis; 1993 Feb; 167(2):498. PubMed ID: 8421190
    [No Abstract]   [Full Text] [Related]  

  • 47. HIV, HTLV-I, and CD4+ lymphocytes. Troubles in the relationship.
    Volberding PA
    JAMA; 1994 Feb; 271(5):392-3. PubMed ID: 7904318
    [No Abstract]   [Full Text] [Related]  

  • 48. Statistical approaches to evaluating prognostic indices in HIV infection (reply).
    Burcham J
    AIDS; 1991 Dec; 5(12):1529. PubMed ID: 1687648
    [No Abstract]   [Full Text] [Related]  

  • 49. Pattern of CD4+ T cell loss in HIV infection.
    Phillips AN; Elford J; Sabin C; Janossy G; Lee CA
    J Acquir Immune Defic Syndr (1988); 1992; 5(9):950-1. PubMed ID: 1355113
    [No Abstract]   [Full Text] [Related]  

  • 50. The immunology of primary HIV infection: which immune responses control HIV replication?
    Safrit JT; Koup RA
    Curr Opin Immunol; 1995 Aug; 7(4):456-61. PubMed ID: 7495508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunopathogenic mechanisms of human immunodeficiency virus disease: implications for therapy.
    Fauci A
    Am J Med; 1995 Dec; 99(6A):59S-60S. PubMed ID: 8585539
    [No Abstract]   [Full Text] [Related]  

  • 52. Measurement of CD4+ percentage.
    Olson PE; Wallace MR
    JAMA; 1994 Aug; 272(6):434. PubMed ID: 7913729
    [No Abstract]   [Full Text] [Related]  

  • 53. Estimating prognosis in HIV-1 infection.
    Phair JP
    Ann Intern Med; 1993 May; 118(9):742-4. PubMed ID: 8096375
    [No Abstract]   [Full Text] [Related]  

  • 54. Prognostic markers for HIV disease progression.
    Katz MH
    Am J Med; 1991 Nov; 91(5):561. PubMed ID: 1683153
    [No Abstract]   [Full Text] [Related]  

  • 55. Editorial: CD4+ T cells in HIV: A Friend or a Foe?
    Govindaraj S; Babu H; Kannanganat S; Vaccari M; Petrovas C; Velu V
    Front Immunol; 2023; 14():1203531. PubMed ID: 37497218
    [No Abstract]   [Full Text] [Related]  

  • 56. Hypoalbuminemia in human immunodeficiency virus infection: causes and possible prognostic value.
    Cirasino L; Landonio G; Imbriani M
    JPEN J Parenter Enteral Nutr; 1993; 17(1):101-2. PubMed ID: 8094764
    [No Abstract]   [Full Text] [Related]  

  • 57. Blocking of HIV entry through CD44-hyaluronic acid interactions.
    Turville S
    Immunol Cell Biol; 2014 Oct; 92(9):735-6. PubMed ID: 25155464
    [No Abstract]   [Full Text] [Related]  

  • 58. A slew of science in Seattle: CROI served up a snapshot of HIV's Envelope trimer and the latest on PrEP and protective immune responses.
    McEnery R; Jefferys R
    IAVI Rep; 2012; 16(2):4-9, 21. PubMed ID: 22650053
    [No Abstract]   [Full Text] [Related]  

  • 59. HIV infection in the Edinburgh haemophiliac cohort.
    Smith GM; McVerry BA; Cooper EH
    BMJ; 1990 Dec; 301(6765):1395-6. PubMed ID: 1980222
    [No Abstract]   [Full Text] [Related]  

  • 60. HIV transmission and immune protection at mucosal surfaces.
    Neutra MR
    Adv Exp Med Biol; 1998; 452():169-75. PubMed ID: 9889970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.